Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

american regent, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. none known.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

laboratorios grifols sa - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37) - sodium chloride 9 g in 1000 ml - sodium chloride injection, usp is indicated as a source of water and electrolytes. 0.9% sodium chloride injection, usp is also indicated for use as a priming solution in hemodialysis procedures. none known.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

liebel-flarsheim company llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride .9 mg in 1 ml - - 125 ml syringe:  sodium chloride injection usp 0.9% is indicated for use in flushing compatible contrast agents through liebel-flarsheim intravenous administration sets into indwelling intravascular access devices only when delivered by the following liebel-flarsheim power injectors: angiomat® , illumena® , illumena® néo, ct9000® , ct9000® adv, optistat® , optivantage® and optistar elite. none risk summary administration of sodium chloride injection usp 0.9% is not known to cause major birth defects, miscarriage or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with sodium chloride injection usp 0.9.% all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary appropriate administration of sodium chloride injection usp 0.9% is not known to cause ha

Μάλτα - Αγγλικά - Medicines Authority

ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - cromoglicate sodium - eye drops, solution - cromoglicate sodium 20 mg/ml - ophthalmologicals

Μάλτα - Αγγλικά - Medicines Authority

sanofi malta limited - cromoglicate sodium - eye drops, solution - cromoglicate sodium 2 % (w/v) - ophthalmologicals

Μάλτα - Αγγλικά - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - cromoglicate sodium - eye drops, solution - cromoglicate sodium 2 % (w/v) - ophthalmologicals

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - sodium cromoglicate 10 mg/ml - solution for inhalation - 20 mg/2ml - active: sodium cromoglicate 10 mg/ml excipient: water for injection

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 1 ml - 23.4% sodium chloride injection, usp is indicated for use as an electrolyte replenisher in parenteral fluid therapy. it serves as an additive for total parenteral nutrition (tpn) and as an additive for carbohydrate containing i.v. fluids. 23.4% sodium chloride injection, usp additive solution is contraindicated in patients with hypernatremia or fluid retention.

Ισραήλ - Αγγλικά - Ministry of Health

rekah pharmaceutical industry ltd, israel - sodium bicarbonate - tablets - sodium bicarbonate 500 mg - sodium bicarbonate - sodium bicarbonate - antacid.

Ισραήλ - Αγγλικά - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 450 mg / 100 ml - sodium chloride - sodium chloride - supply of water and electrolytes.